Biogen (BIIB) option implied volatility low, shares plunge 25% after discontinuing Alzheimer's trials
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Down)Join SI Premium – FREE
Biogen (NASDAQ: BIIB) March weekly and April call option implied volatility is at 27 compared to its 52-week range of 21 to 45 shares plunge 25% after discontinuing Alzheimer's trials.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) April weekly option implied volatility into quarter results
- General Dynamics (GD) call put ratio 4 calls to 1 put into quarter results and outlook
- IBM (IBM) April weekly option implied volatility into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
